Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00447837 · ClinicalTrials.gov registry record · Phase 2
Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis
A Phase 2 study of Chronic Sinusitis, sponsored by Naryx Pharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 180
- Enrollment target
- 20
- Study locations
NCT00447837: Completed Phase 2 study of Chronic Sinusitis, sponsored by Naryx Pharma.
NCT00447837 is a Phase 2 study of Chronic Sinusitis that has completed, run by Naryx Pharma. The registered enrollment target is 180 participants, roughly in line with the 176-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target. The trial reports 20 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00447837, a Phase 2 study of Chronic Sinusitis, has completed, sponsored by Naryx Pharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 180 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
Conditions Studied
Interventions
- DRUG SPRC-AB01
Study Locations (20)
California
- Central California Clinical Research - Fresno
- Allergy Research Foundation, Inc - Los Angeles
- Children's Hospital of Orange County - Orange
- Allergy Medical Group of the North Area Inc - Roseville
- Sacramento Ear, Nose & Throat - Sacramento
- Allergy & Asthma Medical Group and Research Center - San Diego
Florida
- Clinical Trials Management LLC - Boca Raton
- Allergy & Asthma Center / South Florida ENT - Fort Lauderdale
- Clinical Research of West Florida - Tampa
Georgia
- Nasal Sinus and Allergy Institute - Alpharetta
- Northeast Georgia Research Center - Gainsville
- Northside Ear, Nose & Throat - Roswell
Colorado
- 1st Allergy & Clinical Research Center - Centennial
- Colorado Otolaryngology Associates - Colorado Springs
Alabama
- Clinical Research Consultants - Hoover
Arkansas
- NEA Clinic - Jonesboro
Connecticut
- The Connecticut Sinus Center - Bridgeport
Kentucky
- Commonwealth Ear, Nose & Throat - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2006-10 |
| Est. Completion | 2008-01 |
| Phase | Phase 2 |
What the finished NCT00447837 record still lists
NCT00447837 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 176-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target.
The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which SPRC-AB01 is the first listed.
NCT00447837 names 20 study sites across 10 states, led by California, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT00447837 about?
NCT00447837 is a clinical study titled "Evaluating SPRC-AB01 in Post-Surgical Subjects With Chronic Sinusitis". The primary objective of the study is to evaluate the safety and efficacy of SPRC-AB01 versus placebo for treatment of chronic sinusitis in subjects who have had sinus surgery.
What is the current status of trial NCT00447837?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 180 participants. The study started on 2006-10. Estimated completion is 2008-01.
What conditions does trial NCT00447837 study?
This clinical trial studies the following conditions: Chronic Sinusitis.
What interventions are being tested in trial NCT00447837?
The interventions under investigation include: SPRC-AB01 (DRUG).
Who is sponsoring clinical trial NCT00447837?
This trial is sponsored by Naryx Pharma, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00447837 being conducted?
This trial has 20 study locations across Alabama, Arkansas, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00447837's enrollment target sits among peer trials
180 2nd of 9 the highest of 9 other Chronic Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
COMPLETED · Phase 2
-
Esmolol vs. Labetalol in Endoscopic Sinus Surgery
COMPLETED · Phase 2
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
COMPLETED · NA
-
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia